Gala Pharmaceutical Inc. (fka GLPH)

[beenhadbefore]

Look at all the share issued to themselves. This is shell abuse!

For the three months ended May 31, 2017,
there were the following equity transactions.
(j)
On March 22, 2017, the Company issued 490,742 common shares with a fair value of $176,667 to settle
outstanding debt of $88,333 owed to a director of
the Company for legal services.
(ii)
On March 22, 2017, the Company issued 1,387,970 common shares to settle outstanding debt of $249,835
owed to a company controlled by a director of the
Company.
(iii)
On March 30, 2017, the Company issued 10,000,000 common shares with a fair value of $200,000 to
a director of the Company for compensation services
for a period of twelve months from the date of issuance. As at May 31, 2017,
deferred compensation of $165,479 has been recorded in prepaid expense.
(iv)
On March 30, 2017, the Company issued 10,000,000 common shares with a fair value of $200,000 to
a director of the Company for compensation services
for a period of twelve months from the date of issuance. As at May 31, 2017,
deferred compensation of $165,479 has been recorded in prepaid expense.
(v)
On March 30, 2017, the Company issued 1,500,000 common shares with a fair value of $30,000 to the
Chief Financial Officer of the Company for
compensation services for a period of twelve months from the date of issuance. As at
May 31, 2017, deferred compensation of $24,822 has been recorded in
prepaid expense.
(vi)
On March 30, 2017, the Company issued 1,500,000 common shares with a fair value of $30,000 to an
officer of the Company for compensation services for
a period of twelve months from the date of issuance. As at May 31, 2017, deferred
compensation of $24,822 has been recorded in prepaid expense.
(vii)
On May 17, 2017, the Company issued 1,500,000 common shares with a fair value of $30,000 to the
Chief Executive Officer of the Company for
compensation services for a period of twelve months from the date of issuance. As at
May 31, 2017, deferred compensation of $28,767 has been recorded in
prepaid expense.
(viii)
On May 17, 2017, the Company issued 5,000,000 common shares with a fair value of $100,000 to a
company controlled by the Chief Executive Officer of
the Company for the purchase of intangible assets.
(ix)
On May 15, 2017, the Company issued 486,786 share purchase warrants with an exercise price of $0.09
per share for a period of five years.

Info source:
https://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=12195761

Greedy pigs